Relapsed Classic Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Relapsed Classic Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma (NCT04561206) | City of Hope Medical Center | 2021-11-12 |
Track Relapsed Classic Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.